Patient/Doctor meeting 16th May is postponed due to the Corona Virus. If you have purchased rail tickets from LNER they are offering full refunds via their website.
Read More >>News
Patient/Doctor meeting 16th May is postponed due to the Corona Virus
March 16th, 2020August 29th, 2019
September is Thyroid Cancer Awareness Month .Watch our latest TV AD here ; https://youtu.be/YMJ_eK5FOu4
Read More >>World Thyroid Cancer Rome June 2019
July 8th, 2019World Thyroid Cancer Rome June 2019 BTCT was represented at the World Congress on Thyroid Cancer by Consultant Thyroid Cancer Surgeon Mr Peter Truran FRCS from the Royal Victoria Infirmary in Newcastle. Pete presented our work on the update of RAI rooms across the UK to make the patient experience better. Pete says : The […]
Read More >>Selimetry Trial
October 26th, 2018The Selimetry trial has now closed. There is a new trial underway for patients whose thyroid cancer is no longer responsive the RAI treatment. Your oncologist will have to ensure that you fit into the criteria necessary for the trial. You can be referred to any of the following centres . Bristol Haematology and Oncology […]
Read More >>New Patient Survey
September 24th, 2018This study run by the University of Sheffield and Sheffield Teaching Hospitals aims to determine patients’ quality of life following surgery for either thyroid or parathyroid disease. The survey will take 10 minutes to complete. The focus of this study is to look in depth at the effect of low blood calcium levels, one of […]
Read More >>A new clinical trial for people whose thyroid cancer is deemed low risk
August 6th, 2018A new clinical trial is being proposed for people whose thyroid cancer is deemed ‘low risk and we would like to know how patients feel about this . If you were told that your thyroid cancer when you were given the diagnosis please could you help us by taking this short survey? Many thanks ! […]
Read More >>NICE decision on Lenvatenib and Sorafenib
July 13th, 2018NICE have finally given their decision on Lenvatenib and Sorafenib. Both drugs are recommended for the treatment of thyroid cancer which is no longer taking up RAI. However,patients can only have access to one of the drugs. This means that patients who are already taking Sorafenib will not be able to have Lenvatenib when and […]
Read More >>GDPR 2018
April 30th, 2018New data protection rules are coming into force 25th May 2018. We will be contacting all of our members to ask them to ‘opt back in’ by sending us an email to say that they would like to remain a member of BTCT and that they understand that we hold their details on file via […]
Read More >>Project RAI Revamp
April 30th, 2018Project RAI re vamp is well underway with more than 15 RAI units across the UK having benefited from a refurb courtesy of BTCT. Patients are delighted to be able to have their RAI treatment in a room that is warm and welcoming . Take a look at what we are doing : https://m.youtube.com/watch?v=314aLfJAwTU&feature=youtu.be Does […]
Read More >>World Congress on Thyroid Cancer 2017
October 26th, 2017See Dr Tom Milner’s presentation of our RAI Patient Survey at the World Congress on Thyroid Cancer 2017 – click here.
Read More >>Please leave a message on our answer phone and we will get back to you as soon as we can.
Email: amy@butterfly.org.uk
Scan our QR code to donate today!

Excellence in Oncology
'Bright Ideas'
Highly Recommended




